Skip to main content
. 2023 Apr 13;24(8):7177. doi: 10.3390/ijms24087177

Table 2.

Baseline laboratory findings of studied COVID-19 patients.

Parameters Control Moderate
COVID-19
Severe
COVID-19
Critical
COVID-19
p-Value
HB (g/dL) 12.9 ± 2 13 ±1.2 13.17 ± 0.9 12.41 ± 1.7 0.91
PLT (×103/µL) 230.9 ± 71.5 215.3 ± 76.8 239.5 ± 81.7 233.8 ± 102.4 0.519
TLC (×103/µL) 6.9 ± 1.7 7.7 ± 4.2 8.1 ± 3.4 12.8 ± 7.4 0.001 *
Neutrophils (%) 74.5 ± 9.4 76.8 ± 13.5 77.2 ± 12.7 83 ± 10.6 0.001 *
Lymphocyte (%) 19.3 ± 8.2 15.4 ± 10.6 16.2 ± 10.4 11.5 ± 8.5 0.001 *
NLR 7.2 ± 4.1 7.6 ± 5.4 6.6 ± 3.4 13.9 ± 12.6 0.001 *
ALB (g/dL) 3.7 ± 0.3 3.5 ± 0.3 3.4 ± 0.4 3.2 ± 0.5 0.001 *
Calcium (mg/dL) 8.7 ± 0.5 8.7 ± 0.5 8.6 ± 0.5 7.9 ± 1.6 0.001 *
Sodium (mEq/L) 137.1 ± 3.1 136.6 ± 3 136 ± 2.1 138.9 ± 5.7 0.047 *
Potassium (mEq/L) 3.9 ± 0.4 3.6 ± 0.4 3.7 ± 0.5 3.9 ± 0.7 0.078 *
Indirect bilirubin (µg/dL) 0.5 ± 0.2 0.6 ± 0.5 0.5 ± 0.3 0.7 ± 0.3 0.006 *
Direct bilirubin (µg/dL) 0.2 ± 0.09 0.3 ± 0.2 0.2 ± 0.2 0.3 ± 0.3 0.094
PT (seconds) 13.7 ± 1.4 13.5 ± 1.1 14.1 ± 2.2 18.7 ± 9.9 0.001 *
PTT (seconds) 34.4 ± 6.1 35.2 ± 6 38.8 ± 9.4 37.7 ± 8.7 0.015 *
Creatinine (mg/dL) 0.6 ± 0.1 0.7 ± 0.2 0.6 ± 0.1 0.6 ± 0.2 0.213
eGFR (ml/min/1.73 m2) 106.6 ± 16.5 108.8 ± 19.6 103.6 ± 11.2 107.3 ± 17.4 0.247
LDH (IU/L) 168.7 ± 22.3 316.1 ± 101.2 355 ± 104.2 348.2 ± 116.7 0.001 *
CRP (mg/dL) 4.9 ± 1.5 89 ± 32.8 74.7 ± 35.7 91.8 ± 49.8 0.001 *
O2 Saturation (%) 97.5 ± 0.9 94.9 ± 1.2 91.8 ± 1.7 87.4 ± 3.9 0.001 *

Data are presented as mean and standard deviation. One-way ANOVA was used to calculate the p-values. * Significant at p < 0.05. HB: hemoglobin, PLT: platelet, TLC: total leucocytic count, NLR: neutrophils to lymphocyte ratio, ALB: albumin, PT: prothrombin time, PTT: partial thromboplastin time, eGFR: estimated glomerular filtration rate, LDH: lactate dehydrogenase, and CRP: C-reactive protein.